LAVA Therapeutics NV Overview

LAVA Therapeutics NV Cost of Revenue

Cost of Revenue analysis for LVTX.

Quarterly Cost of Revenue

N/A

As of Sep 30, 2025

Annual Cost of Revenue (TTM)

$236000.00

↓ 62.48% YoY

Trailing 12 months ending Sep 30, 2025

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin